18:1 Biotinyl Cap PE
Manufacturer: Sigma Aldrich
CAS Number: 384835-51-2
Synonym(S): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 870273C-25-MG | In Stock | ₹ 21,345.75 |
870273C - 25 MG
In Stock
Quantity
1
Base Price: ₹ 21,345.75
GST (18%): ₹ 3,842.235
Total Price: ₹ 25,187.985
form
liquid
packaging
pkg of 1 × 2.5 mL (870273C-25mg)pkg of 2 × 4 mL (870273C-200mg)
manufacturer/tradename
Avanti Polar Lipids 870273C
concentration
10 mg/mL (870273C-25mg)25 mg/mL (870273C-200mg)
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI
1S/C57H103N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-41-54(64)69-46-49(72-55(65)42-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-71-73(67,68)70-45-44-59-53(63)39-32-31-37-43-58-52(62)40-36-35-38-51-56-50(48-74-51)60-57(66)61-56;/h17-20,49-51,56H,3-16,21-48H2,1-2H3,(H,58,62)(H,59,63)(H,67,68)(H2,60,61,66);/q;+1/p-1/b19-17-,20-18-;/t49-,50+,51+,56+;/m1./s1
InChI key
VQSGNVZURNOPBT-XEAQQBNDSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules Broadpharm / 181 Biotinyl Cap PE / 25mg / 718091971 / BP-28340 / / 384835-51-2 / [null] / 1083.500 / C57H103N4O11PS | eMolecules | ₹ 45,247.55 | |
 | 18:1 Biotinyl Cap PE | Sigma Aldrich | ₹ 23,587.68 - ₹ 99,719.90 | |
 | 18:1 Biotinyl Cap PE | ChemScene | ₹ 86,501.16 | |
 | 384835-51-2 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) | A2B Chem | ₹ 36,020.76 |
Related Products
Description
- General description: 18:1 Biotinyl Cap PE, also known as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) or DOPE-B-Cap, belongs to a class of head group modified functionalized lipids.
- Application: 18:1 Biotinyl Cap PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) has been used in preparation of liposomes[1] and large unilamellar vesicles (LUV).[2]
- Packaging: 5 mL Clear Glass Sealed Ampule (870273C-200mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
form: liquid
packaging: pkg of 1 × 2.5 mL (870273C-25mg)pkg of 2 × 4 mL (870273C-200mg)
manufacturer/tradename: Avanti Polar Lipids 870273C
concentration: 10 mg/mL (870273C-25mg)25 mg/mL (870273C-200mg)
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI: 1S/C57H103N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-41-54(64)69-46-49(72-55(65)42-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-71-73(67,68)70-45-44-59-53(63)39-32-31-37-43-58-52(62)40-36-35-38-51-56-50(48-74-51)60-57(66)61-56;/h17-20,49-51,56H,3-16,21-48H2,1-2H3,(H,58,62)(H,59,63)(H,67,68)(H2,60,61,66);/q;+1/p-1/b19-17-,20-18-;/t49-,50+,51+,56+;/m1./s1
InChI key: VQSGNVZURNOPBT-XEAQQBNDSA-M
form: powder
packaging: pkg of 2 × 100 mg (870273P-200mg)pkg of 1 × 25 mg (870273P-25mg)
manufacturer/tradename: Avanti Polar Lipids 870273P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI: 1S/C57H103N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-41-54(64)69-46-49(72-55(65)42-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-71-73(67,68)70-45-44-59-53(63)39-32-31-37-43-58-52(62)40-36-35-38-51-56-50(48-74-51)60-57(66)61-56;/h17-20,49-51,56H,3-16,21-48H2,1-2H3,(H,58,62)(H,59,63)(H,67,68)(H2,60,61,66);/q;+1/p-1/b19-17-,20-18-;/t49-,50+,51+,56+;/m1./s1
InChI key: VQSGNVZURNOPBT-XEAQQBNDSA-M
form: powder
packaging: pkg of 1 × 100 mg (870277P-100mg)pkg of 1 × 25 mg (870277P-25mg)
manufacturer/tradename: Avanti Polar Lipids 870277P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI: 1S/C53H99N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-29-37-50(60)65-42-45(68-51(61)38-30-26-24-22-20-18-16-14-12-10-8-6-4-2)43-67-69(63,64)66-41-40-55-49(59)35-28-27-33-39-54-48(58)36-32-31-34-47-52-46(44-70-47)56-53(62)57-52;/h45-47,52H,3-44H2,1-2H3,(H,54,58)(H,55,59)(H,63,64)(H2,56,57,62);/q;+1/p-1/t45-,46+,47+,52+;/m1./s1
InChI key: HLOYGXYDOICSBP-OHXMQTJZSA-M
